{"id":"https://openalex.org/W2471518212","doi":"https://doi.org/10.1145/2930971.2930977","title":"Quantifying Self-Reported Adverse Drug Events on Twitter","display_name":"Quantifying Self-Reported Adverse Drug Events on Twitter","publication_year":2016,"publication_date":"2016-01-01","ids":{"openalex":"https://openalex.org/W2471518212","doi":"https://doi.org/10.1145/2930971.2930977","mag":"2471518212"},"language":"en","primary_location":{"id":"doi:10.1145/2930971.2930977","is_oa":false,"landing_page_url":"https://doi.org/10.1145/2930971.2930977","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the 7th 2016 International Conference on Social Media & Society - SMSociety '16","raw_type":"proceedings-article"},"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110866799","display_name":"Vassilis Plachouras","orcid":null},"institutions":[{"id":"https://openalex.org/I4210090249","display_name":"Thomson Reuters (United Kingdom)","ror":"https://ror.org/008krtd86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210090249","https://openalex.org/I68384125"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Vassilis Plachouras","raw_affiliation_strings":["Thomson Reuters Research & Development, London, UK"],"affiliations":[{"raw_affiliation_string":"Thomson Reuters Research & Development, London, UK","institution_ids":["https://openalex.org/I4210090249"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078661113","display_name":"Jochen L. Leidner","orcid":"https://orcid.org/0000-0002-1219-4696"},"institutions":[{"id":"https://openalex.org/I4210090249","display_name":"Thomson Reuters (United Kingdom)","ror":"https://ror.org/008krtd86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210090249","https://openalex.org/I68384125"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jochen L. Leidner","raw_affiliation_strings":["Thomson Reuters Research & Development, London, UK"],"affiliations":[{"raw_affiliation_string":"Thomson Reuters Research & Development, London, UK","institution_ids":["https://openalex.org/I4210090249"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024911553","display_name":"Andrew G. Garrow","orcid":null},"institutions":[{"id":"https://openalex.org/I4210090249","display_name":"Thomson Reuters (United Kingdom)","ror":"https://ror.org/008krtd86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210090249","https://openalex.org/I68384125"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew G. Garrow","raw_affiliation_strings":["Thomson Reuters IP & Science, London, UK"],"affiliations":[{"raw_affiliation_string":"Thomson Reuters IP & Science, London, UK","institution_ids":["https://openalex.org/I4210090249"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5110866799"],"corresponding_institution_ids":["https://openalex.org/I4210090249"],"apc_list":null,"apc_paid":null,"fwci":3.2654,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.9080353,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":null,"issue":null,"first_page":"1","last_page":"10"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9991000294685364,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9991000294685364,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9854999780654907,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11492","display_name":"Academic integrity and plagiarism","score":0.9840999841690063,"subfield":{"id":"https://openalex.org/subfields/3311","display_name":"Safety Research"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/computer-science","display_name":"Computer science","score":0.5507243871688843},{"id":"https://openalex.org/keywords/drug","display_name":"Drug","score":0.49166685342788696},{"id":"https://openalex.org/keywords/internet-privacy","display_name":"Internet privacy","score":0.328583300113678},{"id":"https://openalex.org/keywords/data-science","display_name":"Data science","score":0.322710245847702},{"id":"https://openalex.org/keywords/medicine","display_name":"Medicine","score":0.20024928450584412},{"id":"https://openalex.org/keywords/pharmacology","display_name":"Pharmacology","score":0.11061862111091614}],"concepts":[{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.5507243871688843},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.49166685342788696},{"id":"https://openalex.org/C108827166","wikidata":"https://www.wikidata.org/wiki/Q175975","display_name":"Internet privacy","level":1,"score":0.328583300113678},{"id":"https://openalex.org/C2522767166","wikidata":"https://www.wikidata.org/wiki/Q2374463","display_name":"Data science","level":1,"score":0.322710245847702},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.20024928450584412},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.11061862111091614}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1145/2930971.2930977","is_oa":false,"landing_page_url":"https://doi.org/10.1145/2930971.2930977","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the 7th 2016 International Conference on Social Media & Society - SMSociety '16","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W42186646","https://openalex.org/W93323284","https://openalex.org/W136956327","https://openalex.org/W141818611","https://openalex.org/W157320947","https://openalex.org/W240701929","https://openalex.org/W826376736","https://openalex.org/W872111569","https://openalex.org/W1988100739","https://openalex.org/W2002664886","https://openalex.org/W2007628554","https://openalex.org/W2009890917","https://openalex.org/W2040717102","https://openalex.org/W2058846446","https://openalex.org/W2067082243","https://openalex.org/W2071478164","https://openalex.org/W2085793257","https://openalex.org/W2102742655","https://openalex.org/W2104088534","https://openalex.org/W2110646369","https://openalex.org/W2113235062","https://openalex.org/W2142572836","https://openalex.org/W2153635508","https://openalex.org/W2154359981","https://openalex.org/W2159473174","https://openalex.org/W2164777277","https://openalex.org/W2165530491","https://openalex.org/W2169200297","https://openalex.org/W2171469118","https://openalex.org/W2291928379","https://openalex.org/W2317693431","https://openalex.org/W2553986095","https://openalex.org/W3120421331"],"related_works":["https://openalex.org/W2899084033","https://openalex.org/W2748952813","https://openalex.org/W2390279801","https://openalex.org/W2358668433","https://openalex.org/W2093578348","https://openalex.org/W2376932109","https://openalex.org/W2382290278","https://openalex.org/W2766271392","https://openalex.org/W2350741829","https://openalex.org/W1996408511"],"abstract_inverted_index":{"When":[0],"a":[1,9,112],"drug":[2,15,28],"that":[3],"is":[4,89,108,122],"sold":[5],"exhibits":[6],"side":[7],"effects,":[8],"well":[10],"functioning":[11],"ecosystem":[12],"of":[13,50],"pharmaceutical":[14,21,135],"suppliers":[16],"includes":[17],"responsive":[18],"regulators":[19],"and":[20,55],"companies.":[22],"Existing":[23],"systems":[24],"for":[25,52,111],"monitoring":[26],"adverse":[27,66],"events,":[29],"such":[30],"as":[31],"the":[32,40,48],"Federal":[33],"Adverse":[34],"Events":[35],"Reporting":[36],"System":[37],"(FAERS)":[38],"in":[39,68,79,132],"US,":[41],"have":[42],"shown":[43],"limited":[44],"effectiveness":[45],"due":[46],"to":[47,62,76,81],"lack":[49],"incentives":[51],"healthcare":[53],"professionals":[54],"patients.":[56],"While":[57],"social":[58,95],"media":[59,96],"present":[60],"opportunities":[61],"mine":[63],"information":[64],"about":[65],"events":[67],"near":[69],"real-time,":[70],"there":[71,107],"are":[72,128],"still":[73],"important":[74],"questions":[75],"be":[77],"answered":[78],"order":[80],"understand":[82],"their":[83],"impact":[84],"on":[85,101,117],"pharmacovigilance.":[86],"First,":[87],"it":[88,121],"not":[90,123],"known":[91,124],"how":[92],"many":[93],"relevant":[94],"posts":[97,133],"occur":[98],"per":[99],"day":[100],"platforms":[102],"like":[103],"Twitter,":[104],"i.e.,":[105],"whether":[106],"\"enough":[109],"signal\"":[110],"post-market":[113],"pharmacovigilance":[114],"program":[115],"based":[116],"Twitter":[118],"mining.":[119],"Second,":[120],"what":[125],"other":[126],"topics":[127],"discussed":[129],"by":[130],"users":[131],"mentioning":[134],"drugs.":[136]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":7},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":1}],"updated_date":"2025-11-06T03:46:38.306776","created_date":"2025-10-10T00:00:00"}